-
- Sign In
- Tests
-
Invitae testsFollow-up testingFrequently ordered panels
- How to order
-
Getting startedEssentialsSponsored programs
- Start an order
- How to place an order
- Request a kit
- Forms
- Billing information
- In-network health plans
- Specimen requirements
- Behind the Seizure
- Alnylam Act hATTR amyloidosis
- Alnylam Act Acute Hepatic Porphyrias
- Alnylam Act Primary Hyperoxaluria Type 1
- Uncovering Periodic Paralysis
- SMA Identified
- hypophosphatemia
- Resources
-
Clinical resourcesEducational materialsWorking together
- Technology
-
Our technologyA new gold standardData sharing
- FAQ
- FOR PATIENTS
- CONTACT
- FAQs / SUPPORT
- New: Sponsored, no-charge hypophosphatemia genetic testing for patients ≥1 year old. More >
- Non-invasive prenatal screening now available. Learn more.
- Behind the Seizure™: Sponsored, no-cost epilepsy gene testing program now includes children up to 60 months old. Learn more.
- The ASBrS recommends genetic testing be available to all breast cancer patients. Learn more.
- Coming soon: Invitae will launch patient-initiated testing in 2019. Sign up to learn more.
Explore our genetic test catalog
Diagnostics
Confirm a diagnosis, provide a better understanding of prognosis, and direct medical management
Reproductive health
Help make healthy pregnancies possible with carrier screening and preimplantation testing
Proactive health
Determine a healthy adult’s predisposition to cancer, cardiovascular conditions, and more
